PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
07-Feb-2020 MagBio Genomics, Inc. Receives ISO 9001:2015 Accreditation for Quality Management System MagBio Genomics, Inc
07-Feb-2020 Novartis Cosentyx® builds on its axSpA leadership with US label update for dosing flexibility in ankylosing spondylitis Novartis
07-Feb-2020 Proposed Placing and Subscription to raise a minimum of £5 million Open Orphan plc
07-Feb-2020 AI in healthcare sector in rude health finnCap Group
07-Feb-2020 OGT launches breakthrough CytoSure NGS panel for constitutional cytogenetics Oxford Gene Technology
07-Feb-2020 Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study Sumitomo Dainippon Pharma Co., Ltd
07-Feb-2020 Johnson & Johnson in Healthy Lead as World’s Most Valuable Pharma Brand Brand Finance
07-Feb-2020 Panthera’s clinical trial site in Preston, UK, open for business Panthera
07-Feb-2020 : Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA Immutep
07-Feb-2020 2019 EBITDA ahead of market expectations Outlook underpinned by strong order book and Ashfield Pharmacovigilance acquisition Ergomed plc
07-Feb-2020 Chiesi Group receives Top Employer Award in UK and Europe for eighth consecutive year Chiesi
06-Feb-2020 Envision Pharma Group kick off 2020 by scooping a triple win at the PM Society Awards Envision Pharma Group
03-Feb-2020 Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services Inceptua
31-Jan-2020 Reich Insurance launches innovative online Life Sciences insurance quote portal Reich Insurance Group
30-Jan-2020 Santhera Reports Net Revenues 2019 and Highlights Pipeline Progress Santhera Pharmaceuticals Holding AG
29-Jan-2020 Clasado CEO Per Rehné joins Global Prebiotic Association’s Communications Committee Clasado Biosciences
29-Jan-2020 New Interactive Good Clinical Practice online learning course now available Jo Burmester
28-Jan-2020 Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference SMi Group
24-Jan-2020 Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1 Sanofi
24-Jan-2020 Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1 Sanofi